Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial. - Wikidata - awgldk - TriplyDB

Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial.

Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial.

http://www.wikidata.org/entity/Q37185366

about

Sex Differences in Behavioral Dyscontrol: Role in Drug Addiction and Novel Treatments The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders Gambling disorder: an integrative review of animal and human studies.Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us?An update on the pharmacotherapy of attention-deficit/hyperactivity disorder in adults Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models.A placebo-controlled trial of atomoxetine in marijuana-dependent individuals with attention deficit hyperactivity disorder Off-label use of atomoxetine in adults: is it safe?A pilot study of neurocognitive function in older and younger cocaine abusers and controls.Effects of the combination of wheel running and atomoxetine on cue- and cocaine-primed reinstatement in rats selected for high or low impulsivity.Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit/hyperactivity disorder.Atomoxetine does not alter cocaine use in cocaine dependent individuals: double blind randomized trial.Sex differences in reinstatement of cocaine-seeking with combination treatments of progesterone and atomoxetine Correlates of alcohol use in adults with ADHD and comorbid alcohol use disorders: exploratory analysis of a placebo-controlled trial of atomoxetine A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities.Pharmacological and clinical dilemmas of prescribing in co-morbid adult attention-deficit/hyperactivity disorder and addiction.Noradrenergic modulation of cognition: therapeutic implications.Atomoxetine effects on attentional bias to drug-related cues in cocaine dependent individuals.Sex differences in the reduction of impulsive choice (delay discounting) for cocaine in rats with atomoxetine and progesterone.Subchronic administration of atomoxetine causes an enduring reduction in context-induced relapse to cocaine seeking without affecting impulsive decision making.Atomoxetine in abstinent cocaine users: Cognitive, subjective and cardiovascular effects.

P2860

Q26768148-263D2BA1-5979-4D17-B4A9-5B5802CD7665 Q26851607-CD1A0131-7702-4D12-8C95-BF2750BD12F4 Q30234518-36B3658E-FFC9-407A-9868-F8A18E7CA839 Q33919950-EB23DCF2-8546-4966-9DEB-3AD8CA7F6C4A Q34220004-8366D9C0-E8ED-470D-9588-DAD3A1F14B29 Q34407185-3729351E-3689-4C9F-94C0-EE0BF3DA9604 Q34481402-22A2271B-E581-4C40-AE63-DEEC8B271DB9 Q34618993-7694563C-DED2-4C80-8A17-7DC7123621FF Q34789518-58154DD2-D09B-4105-ACE4-BA57BBDD8F46 Q35117860-8B4B243A-842E-44C5-AB4B-1189EA06DF24 Q35625911-B200EA3B-B960-4E3A-962B-A029007B16E7 Q36857705-E6E032F0-5C2F-4B95-AC95-9BB87C458574 Q36892871-F47E3FA2-F8A4-4291-9356-CF13B622CFCA Q37169714-7E6806CD-BCEB-4C40-8C26-A90BA7403473 Q37638740-A08C625E-0FCD-490F-B806-2BD584D1334F Q38065287-DE0176E8-EEA3-4481-8888-90AD7F429EC4 Q38091914-43E8016D-5722-4196-84F7-C2A7B104A99A Q38678085-7E3825A4-B51E-4D0D-8430-4A8FAA0211F3 Q42429841-C6F3B34E-FF14-42D7-A40B-A05132B40E6B Q44895119-AEF2076D-F7B1-4056-82A9-6F9ABBC26B27 Q47823644-529E363E-A13C-44A1-ABC5-D6EE74B7492C

P2860

Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial.

http://www.wikidata.org/entity/Q37185366

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Atomoxetine Treatment for Coca ...... HD): A Preliminary Open Trial.

@en

Atomoxetine Treatment for Coca ...... Deficit Hyperactivity Disorder

@nl

type

label

Atomoxetine Treatment for Coca ...... HD): A Preliminary Open Trial.

@en

Atomoxetine Treatment for Coca ...... Deficit Hyperactivity Disorder

@nl

prefLabel

Atomoxetine Treatment for Coca ...... HD): A Preliminary Open Trial.

@en

Atomoxetine Treatment for Coca ...... Deficit Hyperactivity Disorder

@nl

P1433

Q37185366-06FAEA97-93E2-4C4E-A7D5-7097A064A50E

P1476

Q37185366-C69D537B-9852-4D19-AD3C-FD7D3CC9FF09

P2093

Q37185366-07479C3F-6A0A-4ACD-8CB7-FC2918234AF9

Q37185366-1740305B-00EF-41ED-A40E-08E7CB7D5710

Q37185366-6D4FA98B-14F5-4242-AC7F-1E74394B4D65

Q37185366-8B287E24-A85A-4B3A-8178-81A3FD43C484

Q37185366-9C297DED-498B-4612-9D67-4FC9CC804841

Q37185366-A40B0D56-5E44-49A7-BC45-DE91685E186F

Q37185366-AA2295FB-F9C9-4EAC-B80B-6AFBFF6B37E4

Q37185366-E05A9E3D-8010-4C04-87A8-281751E47507

Q37185366-FC09ACCD-076E-4F9D-8A07-4CB413410ED7

P2860

Q37185366-028C349C-65CB-4008-B54E-C20730E409BA

Q37185366-046F5028-9ECA-48DF-9543-D87CA71AF093

Q37185366-0855A59D-8C21-4F6F-8E22-A1E4FD328A31

Q37185366-10065A0C-9476-4E44-8073-3F00025DE566

Q37185366-1C81CB52-CEFE-411D-84CF-7CF02A1B2443

Q37185366-1EB616EB-01DF-4A28-909D-438879A18833

Q37185366-26C1591D-36D5-41BB-B88A-CE66B13F6C69

Q37185366-29F5E2EA-F5A0-4603-AF0C-91E77FF77AE7

Q37185366-2D95491F-6F6E-4A03-B93E-4D9D8B1067E5

Q37185366-3FFBD755-110B-4DD7-8C5B-1F241BB6F46D

P304

Q37185366-070C2F9A-9867-4733-B2F9-0C50F0E657CC

P31

Q37185366-F213F146-E44B-47E5-9CAF-750B91A005EE

P356

Q37185366-AE411315-DD8E-4873-870C-B383C42E7AF4

P433

Q37185366-5559A1E4-E4EE-4F2D-9528-8E50AE730E1E

P478

Q37185366-CFFAA6F1-AC76-46C5-B90B-9189601D49F3

P50

Q37185366-03C5AC33-6BE4-4DB6-9A92-FC8A3F76A630

P577

Q37185366-CB88CA4E-02FF-43A3-A624-8E9801DDDB35

P5875

Q37185366-525F97EC-ECFB-419C-8102-3DEBF83F3F39

P698

Q37185366-7D66B86F-ACB2-4686-AB35-DDE55AEDE5E7

P921

Q37185366-9BEFB4E4-4507-436F-96BB-7DE3BA4DD170

Q37185366-E1DADB5C-AB7C-4FD0-B3EF-E3BA99EE95BA

P932

Q37185366-F8AA02E9-5416-418D-8505-80DC0A463323

P356

15504260802628767

P1433

Journal of Dual Diagnosis

P1476

Atomoxetine Treatment for Coca ...... HD): A Preliminary Open Trial.

@en

P2093

Alex Secora

http://www.w3.org/2001/XMLSchema#string

Daniel Brooks

http://www.w3.org/2001/XMLSchema#string

Edward Nunes

http://www.w3.org/2001/XMLSchema#string

Efrat Aharonovich

http://www.w3.org/2001/XMLSchema#string

Frances R Levin

http://www.w3.org/2001/XMLSchema#string

Grace Hennessy

http://www.w3.org/2001/XMLSchema#string

John J Mariani

http://www.w3.org/2001/XMLSchema#string

Wendy Y Cheng

http://www.w3.org/2001/XMLSchema#string

Wilfrid Raby

http://www.w3.org/2001/XMLSchema#string

P2860

Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature

Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder

The neural basis of addiction: a pathology of motivation and choice

Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.

Dual diagnosis and successful participation of adolescents in substance abuse treatment.

Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder.

Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence.

Treatment strategies for co-occurring ADHD and substance use disorders

P304

41-56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/15504260802628767

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24416170

http://www.w3.org/2001/XMLSchema#string

P698

19430599

http://www.w3.org/2001/XMLSchema#string

P921

attention deficit hyperactivity disorder

P932

2679511

http://www.w3.org/2001/XMLSchema#string